tyramine has been researched along with dipyridamole in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (62.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Himori, N; Taira, N | 1 |
Hashimoto, K; Sakai, K; Yasuda, K | 1 |
Gokel, M; Haas, H | 1 |
Hashimoto, K; Sato, S; Yasuda, K | 1 |
Yasuda, K | 1 |
Chiba, S; Naito, M; Yang, XP | 1 |
1 review(s) available for tyramine and dipyridamole
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for tyramine and dipyridamole
Article | Year |
---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Release of noradrenaline proposed as a mechanisms for the positive inotropic action of dipyridamole.
Topics: Animals; Desipramine; Dipyridamole; Dogs; Myocardial Contraction; Norepinephrine; Papillary Muscles; Propranolol; Reserpine; Stimulation, Chemical; Tetrodotoxin; Tyramine | 1976 |
Role of catecholamine and adenosine in the ischemic response following release of a renal artery occlusion.
Topics: Acetylcholine; Angiotensin II; Animals; Atropine; Blood Pressure; Catecholamines; Creatinine; Dipyridamole; Dogs; Female; Hexamethonium Compounds; Hypoxanthines; Male; Norepinephrine; Nucleosides; Phenoxybenzamine; Renal Artery; Renal Artery Obstruction; Reserpine; Serotonin; Tolazoline; Tyramine; Vasomotor System | 1968 |
[Effect of Verapamil on the metabolism of myocardium].
Topics: Adenine Nucleotides; Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Asphyxia; Blood Glucose; Blood Pressure; Creatine; Depression, Chemical; Dipyridamole; Dogs; Ethanolamines; Fatty Acids; Heart Rate; Hypoxia; Lactates; Male; Mice; Myocardium; Nitriles; Norepinephrine; Oxidation-Reduction; Phosphates; Prenylamine; Propranolol; Pyruvates; Rats; Stimulation, Chemical; Sympatholytics; Sympathomimetics; Theophylline; Tyramine; Vasodilator Agents; Verapamil | 1970 |
Renal vascular effect of dipyridamole: potentiation of norepinephrine and adenosine.
Topics: Animals; Blood Pressure; Dipyridamole; Dogs; Drug Synergism; Female; Kidney; Male; Norepinephrine; Nucleosides; Regional Blood Flow; Renal Artery; Tyramine; Vascular Resistance | 1970 |
[Potentiation of renovascular constrictive action of norepinephrine and adenosine by dipyridamole].
Topics: Adenine Nucleotides; Animals; Constriction; Dipyridamole; Dogs; Drug Synergism; Electric Stimulation; Female; Infusions, Parenteral; Kidney; Male; Norepinephrine; Renal Veins; Tyramine; Vasomotor System | 1970 |
Modification of transmitter release from periarterial nerve terminals by dipyridamole in canine isolated splenic artery.
Topics: Adenosine Triphosphate; Adrenergic Uptake Inhibitors; Animals; Dipyridamole; Dogs; Dose-Response Relationship, Drug; Electric Stimulation; Female; In Vitro Techniques; Male; Nerve Endings; Norepinephrine; Receptors, Adrenergic, alpha-1; Receptors, Purinergic P2; Splenic Artery; Synaptic Transmission; Tyramine; Vasoconstrictor Agents; Vasodilator Agents | 2004 |